Promoting Better Decisions Using Real World Evidence
GPC will identify and convene a diverse group of real world evidence (RWE) users, experts, and stakeholders to develop best practices for using RWE studies to reliably inform decisions by health plans, formulary committees, and clinical guideline developers. This effort will build upon best practices for designers of observational studies already developed by ISPOR, the CER Collaborative, and others. Informed by the needs of a broad range of decision makers and evidence assessors, these best practices will foster transparency and consistency in the way RWE is used by decision makers. In turn, they will significantly increase the confidence of those generating RWE studies in the value of their investments, and help to ensure that decision makers receive the relevant and reliable evidence they need.